Working… Menu
Trial record 1 of 6 for:    "Neuromyelitis Optica" | "Antirheumatic Agents"
Previous Study | Return to List | Next Study

Safety and Tolerability of Rituximab in Neuromyelitis Optica

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00501748
Recruitment Status : Completed
First Posted : July 16, 2007
Last Update Posted : September 27, 2011
Genentech, Inc.
Information provided by (Responsible Party):
University of California, San Francisco

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2010
Actual Study Completion Date : December 2010